Tal Grenader

1.4k total citations
64 papers, 1.0k citations indexed

About

Tal Grenader is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tal Grenader has authored 64 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Tal Grenader's work include Inflammatory Biomarkers in Disease Prognosis (9 papers), BRCA gene mutations in cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Tal Grenader is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (9 papers), BRCA gene mutations in cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Tal Grenader collaborates with scholars based in Israel, United States and United Kingdom. Tal Grenader's co-authors include Linda Shavit, Alberto Gabizón, Hilary Shmeeda, John Bridgewater, Stephen Nash, Tamar Peretz, Meyer D. Lifschitz, J. Oates, Naureen Starling and David Cunningham and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Tal Grenader

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tal Grenader Israel 18 491 224 198 175 141 64 1.0k
Ferdinand Ploner Austria 14 631 1.3× 365 1.6× 149 0.8× 283 1.6× 61 0.4× 27 1.3k
CS McArdle United Kingdom 20 458 0.9× 193 0.9× 331 1.7× 170 1.0× 61 0.4× 52 1.1k
Roberto S Oliveri Denmark 20 459 0.9× 154 0.7× 612 3.1× 303 1.7× 35 0.2× 33 2.0k
Olivier Héquet France 18 367 0.7× 193 0.9× 222 1.1× 169 1.0× 253 1.8× 48 1.5k
Elona Juozaitytė Lithuania 17 397 0.8× 143 0.6× 227 1.1× 169 1.0× 124 0.9× 86 842
Ta‐Chung Chao Taiwan 22 724 1.5× 485 2.2× 139 0.7× 317 1.8× 73 0.5× 99 1.4k
S Biran Israel 16 264 0.5× 131 0.6× 273 1.4× 171 1.0× 133 0.9× 84 977
Siew Wan Hee Singapore 18 393 0.8× 237 1.1× 266 1.3× 112 0.6× 22 0.2× 54 1.2k
Gary V. Burton United States 23 732 1.5× 339 1.5× 200 1.0× 209 1.2× 58 0.4× 68 1.5k
Amanda Roberts Canada 17 340 0.7× 338 1.5× 289 1.5× 122 0.7× 26 0.2× 46 1.2k

Countries citing papers authored by Tal Grenader

Since Specialization
Citations

This map shows the geographic impact of Tal Grenader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Grenader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Grenader more than expected).

Fields of papers citing papers by Tal Grenader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Grenader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Grenader. The network helps show where Tal Grenader may publish in the future.

Co-authorship network of co-authors of Tal Grenader

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Grenader. A scholar is included among the top collaborators of Tal Grenader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Grenader. Tal Grenader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tahover, Esther, Amiel Segal, Rut Isacson, et al.. (2017). Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer. Anti-Cancer Drugs. 28(7). 787–794. 38 indexed citations
2.
Grenader, Tal, Stephen Nash, Richard Adams, et al.. (2016). Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study. British Journal of Cancer. 114(6). 612–615. 55 indexed citations
3.
Grenader, Tal, et al.. (2016). Next-generation sequencing in patients with advanced cancer. Anti-Cancer Drugs. 27(9). 899–907. 2 indexed citations
4.
Gabizon, Alberto, Tal Grenader, Esther Tahover, et al.. (2016). A phase 1B study of pegylated liposomal mitomycin-C prodrug with or without capecitabine and bevacizumab in third line chemotherapy of colorectal cancer. Annals of Oncology. 27. vi202–vi202. 2 indexed citations
5.
Grenader, Tal, Rinat Yerushalmi, Georgeta Fried, et al.. (2014). The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort. Oncology. 87(1). 1–6. 26 indexed citations
6.
Shavit, Linda, Tal Grenader, Meyer D. Lifschitz, & Itzchak Slotki. (2012). Use of Pregabalin in the Management of Chronic Uremic Pruritus. Journal of Pain and Symptom Management. 45(4). 776–781. 37 indexed citations
7.
Grenader, Tal, et al.. (2012). Spontaneous Regression of Metastatic Papillary Renal Cell Cancer After Cessation of Treatment With Sorafenib. Clinical Genitourinary Cancer. 11(2). 201–203. 2 indexed citations
8.
Grenader, Tal & Linda Shavit. (2011). PET scan in a patient with pneumococcal sepsis. Internal and Emergency Medicine. 7(S1). 47–49.
9.
10.
Grenader, Tal, et al.. (2010). Long-Term Survival in a Patient with Non-Small Cell Lung Cancer Presenting as Small Intestinal Obstruction. Onkologie. 33(4). 178–180. 3 indexed citations
11.
Shavit, Linda, et al.. (2010). High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients. Clinical Nephrology. 74(10). 297–302. 5 indexed citations
12.
Grenader, Tal, et al.. (2008). Primary Amelanotic Melanoma of the Vagina. Onkologie. 31(8-9). 474–476. 9 indexed citations
13.
Grenader, Tal, et al.. (2008). Staphylococcus aureus Bacteremia Secondary to Severe Erlotinib Skin Toxicity. Clinical Lung Cancer. 9(1). 59–60. 26 indexed citations
14.
Grenader, Tal, et al.. (2008). Second cancers in patients with male breast cancer: a literature review. Journal of Cancer Survivorship. 2(2). 73–78. 21 indexed citations
15.
Grenader, Tal, et al.. (2007). Significant drug interaction: Phenytoin toxicity due to erlotinib. Lung Cancer. 57(3). 404–406. 30 indexed citations
16.
Grenader, Tal, Linda Shavit, Alexander Lossos, Galina Pizov, & Mark L. Wygoda. (2007). Brain metastases: a rare initial presentation of prostate cancer. International Urology and Nephrology. 39(2). 537–539. 15 indexed citations
17.
18.
Grenader, Tal & Linda Shavit. (2004). Intravenous immunoglobulin in treatment of cardiac tamponade in a patient with systemic lupus erythematosus. Clinical Rheumatology. 23(6). 530–532. 10 indexed citations
19.
Rosenmann, Hanna, Zeev Meiner, Esther Kahana, et al.. (2004). An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 128B(1). 123–125. 9 indexed citations
20.
Rosenmann, Hanna, Zeev Meiner, Esther Kahana, et al.. (2004). The Fas Promoter Polymorphism at Position –670 Is Not Associated with Late-Onset Sporadic Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 17(3). 143–146. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferdinand Ploner Breakdown of academic impact, for papers by CS McArdle Breakdown of academic impact, for papers by Roberto S Oliveri Breakdown of academic impact, for papers by Olivier Héquet Breakdown of academic impact, for papers by Elona Juozaitytė Breakdown of academic impact, for papers by Ta‐Chung Chao Breakdown of academic impact, for papers by S Biran Breakdown of academic impact, for papers by Siew Wan Hee Breakdown of academic impact, for papers by Gary V. Burton Breakdown of academic impact, for papers by Amanda Roberts
Rankless by CCL
2026